June 8, 2000
AMERIPATH ANNOUNCES ASSET IMPAIRMENT AND RELATED
Riviera Beach, FL, June 8, 2000 - AmeriPath, Inc. (Nasdaq:
PATH), the largest physician and laboratory company focused
on providing anatomic pathology diagnostic and healthcare
information services, today announced that it anticipates
recording in the second quarter of 2000 a pre-tax non
cash charge of approximately $4.7 million, and related
cash charges of approximately $540,000, in connection
with the impairment of intangible assets at an acquired
practice in Cleveland, Ohio. These charges will result
in a reduction of net income for the second quarter of
$3.9 million, or $.18 per share, and the Company failing
to meet the analysts' quarterly earnings estimates for
the first time in its history.
As previously disclosed in the Company's 1999 annual
report on Form 10-K and its Form 10-Q for the first quarter,
the Company provided services at four hospitals and an
ambulatory care facility owned by Primary Health Systems
("Primary Health Systems ("PHS"), a regional hospital
network in Cleveland, Ohio. During the first quarter
of 2000, PHS began implementing a plan of reorganization
filed under Chapter 11 with the U.S. Bankruptcy Court
for the District of Delaware, and closed one hospital. During
the second quarter, the bankruptcy court approved the
sale of two hospitals and the ambulatory care facility
to local purchasers in the Cleveland area. The Company's
contracts with these two hospitals and the ambulatory
care facility were not accepted by the purchasers, who
have elected to employ their own pathologists. One hospital
has not been sold or closed and continues to do business
with the Company.
As a consequence, the reduction of profit and related
cash flow requires the Company to write off the remaining
intangible assets, including goodwill, associated with
the original purchase of this practice. In addition,
the Company will record approximately $540,000 of related
charges for potentially uncollectible accounts receivable
in connection with the loss of these contracts, severance
costs, and legal fees. For the first quarter of 2000,
this practice's net revenue and operating profits were
$500,000 and $50,000, respectively, which was less than
1.0% of the Company's consolidated net revenue and operating
profit.
This event could cause the Company to be in technical
default of one or more covenants under the Company's
credit facility. The Company is presently seeking to
obtain a waiver of noncompliance from the lenders under
such facility. Until the formal waiver is obtained,
there can be no assurance that such a waiver will be
obtained, or of the final terms or conditions of any
such waiver.
James C. New, Chairman, President and Chief Executive
Officer commented, "This event does not reflect on our
fundamental business model, but solely on the financial
condition of PHS. Well-run hospital organizations continue
to survive and recognize the benefits of contracting
pathology services with AmeriPath. The Company and this
practice's Managing Director will continue to aggressively
market its services in the Cleveland area through its
existing outpatient lab and relationships with other
hospitals in Ohio."
The Company will broadcast a conference call on Friday,
June 9, 2000 at 10:00 a.m. EDT over the Internet. This
event is available through Investor Broadcast Network's
Vcall website, located at http://www.vcall.com. Listeners
should go to the website at least fifteen minutes before
the event to register, download, and install any necessary
audio software. There is no charge to access the event. A
replay of the call will also be available by telephone
beginning at 12:00 p.m. June 9 to 12:00 p.m. June 10. The
dial-in number is 800-633-8284, reservation #15482672.
AmeriPath, Inc. is the nation's largest physician and
laboratory company focused on providing anatomic pathology
diagnostic and healthcare information services to physicians,
hospitals, national clinical laboratories and managed
care organizations. The company presently operates in
13 states and employs 296 physicians that provide medical
services through outpatient pathology laboratories, hospital
inpatient laboratories and outpatient surgery centers.
